Sharon Shacham

2017

In 2017, Sharon Shacham earned a total compensation of $2.5M as President and Chief Scientific Officer at Karyopharm Therapeutics, a 83% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$171,856
Option Awards$1,857,650
Salary$435,000
Other$11,460
Total$2,475,966

Shacham received $1.9M in option awards, accounting for 75% of the total pay in 2017.

Shacham also received $171.9K in non-equity incentive plan, $435K in salary and $11.5K in other compensation.

Rankings

In 2017, Sharon Shacham's compensation ranked 4,471st out of 14,666 executives tracked by ExecPay. In other words, Shacham earned more than 69.5% of executives.

ClassificationRankingPercentile
All
4,471
out of 14,666
70th
Division
Manufacturing
1,573
out of 5,772
73rd
Major group
Chemicals And Allied Products
453
out of 2,075
78th
Industry group
Drugs
348
out of 1,731
80th
Industry
Pharmaceutical Preparations
275
out of 1,333
79th
Source: SEC filing on April 27, 2018.

Shacham's colleagues

We found two more compensation records of executives who worked with Sharon Shacham at Karyopharm Therapeutics in 2017.

2017

Michael Kauffman

Karyopharm Therapeutics

Chief Executive Officer

2017

Christopher Primiano

Karyopharm Therapeutics

General Counsel

News

In-depth

You may also like